Experience Fenwick Represents Corium in Pending $504M Acquisition By Gurnet Point Capital October 10, 2018
Experience Fenwick Represents Sierra Oncology in Asset Purchase of Momelotinib from Gilead Sciences August 22, 2018
Experience Fenwick Represents ArrowMark Partners in IP Due Diligence of Precision BioSciences’ $110M Series B Financing June 25, 2018
Experience Fenwick Represents Myonexus Therapeutics in its Partnership Agreement with Sarepta Therapeutics May 9, 2018